The January 2020 scorecard for the signals generated from Jet Equities can be downloaded here.
Digital Ally, Inc. (DGLY) announced on February 4 that the company received its largest contract award in history. The contract is worth up to $4 million for the initial delivery of 5,000 police body cameras and ongoing web services. The contract includes web-based infrastructure services for an initial three-year period. Jet Equities detected the […]
On January 24, Casa Systems, Inc. (CASA) increased annual earnings guidance. Fiscal year GAAP revenue guidance increased from between $255 million and $270 million to between $275 million and $280 million. At the same time, the company announced the resignation of its CFO, Maurizio Nicolelli, effective January 31, 2020. Mr. Nicolelli’s departure is not associated […]
On January 16, NV5 Global, Inc. announced that the company has been awarded a new contact for the engineering design of underground power lines in California. The entire project is a multi-year, multi-phase project worth $20 million for NV5. It is part of an effort to mitigate fire risk and reduce service interruptions during windy […]
On January 13, Lannett Company (LCI) announced that the company received FDA approval for its branded local anesthetic product. Lannett submitted a New Drug Application (NDA) to the FDA for for Cocaine Hydrochloride (HCl) Nasal Solution 4% (40 mg/mL). The product should be launched shortly under the name NUMBRINO®. It is a local anesthetic used […]
Neogen Corporation (NEOG) announced on January 13 that it acquired Diessechem, an Italian distributor of food and feed safety diagnostics. Since the company’s founding in 1993, Diessechem has been one of Neogen’s authorized distributors. Diessechem is a leading supplier of diagnostic kits and instruments for food safety and analysis in Italy. Neogen develops and markets […]
On January 9, Aclaris Therapeutics, Inc. (ACRS) reported positive Phase 1 clinical trial results for the investigational compound ATI-450. The compound should help to treat patients with immune-inflammatory diseases. Participants did not experience any serious or severe events, and all adverse events were mild. As a result, Aclaris expects to begin its first Phase 2 […]
The December 2019 scorecard for the signals generated from Jet Equities can be downloaded here.
Sol-Gel Technologies (SLGL) announced on December 30 that the company has positive Phase 3 clinical trial results for Twyneo®. The investigational cream is a combination of tretinoin 0.1% and benzoyl peroxide 3% used for the treatment of acne vulgaris. The results showed statistically significant improvement on all co-primary endpoints and that the treatment was well […]
On December 20, NewLink Genetics Corporation (NLNK) announced that after a priority review, the FDA approved ERVEBO®, or Zaire Ebola virus vaccine V920 (rVSV∆G-ZEBOV-GP). This is the first Ebola vaccine approved by the FDA. Merck (MRK) partnered with NewLink Genetics in the development of the vaccine. Jet Equities detected the event and issued an […]
